Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary TB
Share The Content :
(Refresh the page or download this document incase the PDF doesn't load properly)